Filing Details

Accession Number:
0001466049-10-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-15 12:00:00
Reporting Period:
2010-01-13
Filing Date:
2010-01-15
Accepted Time:
2010-01-15 16:01:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Biodel Inc BIOD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1281446 Great Point Partners Llc 165 Mason Street
3Rd Floor
Greenwich CT 06830
Yes No No No
1397513 David Kroin C/O Biodel Inc
100 Saw Mill Road
Danbury CT 06810
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-13 17,671 $5.01 1,074,762 No 4 S Direct
Common Stock Disposition 2010-01-14 65,574 $5.09 1,009,188 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2009.
  2. This transaction was executed in multiple trades at prices ranging from $5.00 to 5.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $5.00 to 5.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The amount shown represents the beneficial ownership of the issuer's securities by Great Point Partners I, L.P., which may be deemed attributable to Mr. Kroin because Mr. Kroin is a co-founder and managing director of Great Point Partners I, L.P. Mr. Kroin serves as a director of the issuer as a representative of Great Point Partners I, L.P., and accordingly Great Point Partners I, L.P. may be deemed to be a director by deputization. Mr. Kroin disclaims beneficial ownership of the shares except to the extent of his pecuinary interest therein.